Skip to main content
Menu
US

Revvity Blog

Powering innovation from discovery to cure.

Single-cell RNA and protein sequencing as a robust tool for multisite biomarker detection.
Precision Medicine August 21, 2024 - 2 min read
Cancer
Fluorescence imaging is comparable to PET in early detection of tumor metabolism.
Cancer
The top 7 attributes of cell line-derived reference standards for oncology assays.
Cell and Gene Therapy
The future of cell and gene therapy: Revvity at ASGCT.
NGS
Limitations associated with the lack of data analysis tools in metagenomics.
Disease Research
Why use fluorescent probes in your in vivo imaging studies?
Physiological Models
Overcoming the challenges of 3D immune cell-killing assays.
Physiological Models
Making organoids ready for screening.
Precision Medicine
The future of precision medicine: integrating functional approaches for better outcomes.
Precision Medicine
Redefining precision medicine with real-time insights.
Precision Medicine
Precision medicine boosted by functional drug testing using patient-derived model systems.

Questions?
We’re here to help.

Contact us